Jung-Hee Woo

Title: Jung-Hee Woo: Innovator in Immunotoxin Research

Introduction

Jung-Hee Woo is a prominent inventor based in Rockville, MD (US), known for her significant contributions to the field of immunotoxin research. With a total of 6 patents to her name, she has made remarkable advancements in the development of therapeutic agents targeting diseases.

Latest Patents

Among her latest patents are innovative methods and compositions related to diphtheria toxin diabody immunotoxins. One notable patent is the "Fold-back diabody diphtheria toxin immunotoxin and methods of use," which provides methods and compositions for utilizing diphtheria toxin diabody immunotoxins effectively. Another significant patent is "Immunotoxin fusion proteins and means for expression thereof," which describes novel recombinant DT-based immunotoxins, specifically anti-T cell immunotoxin fusion proteins. This invention also includes immunotoxins that can be expressed in various cell types, including bacterial, yeast, or mammalian cells.

Career Highlights

Jung-Hee Woo has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. Her work in these institutions has allowed her to contribute to groundbreaking research and development in the field of immunotoxins.

Collaborations

Throughout her career, Jung-Hee Woo has collaborated with notable colleagues, including David M. Neville and Jerry Todd Thompson. These collaborations have further enriched her research and innovation in immunotoxin therapies.

Conclusion

Jung-Hee Woo's contributions to immunotoxin research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in healthcare.